Unusually, Amgen acknowledges the quandary in its press release about the US FDA approval of Repatha, where Anthony Hooper, the company's vice president of commercial operations, says the company ...

The lower-priced version of Repatha was introduced a year ago in ... need to be addressed,” said Murdo Gordon, head of global commercial operations at the big biotech. “We are discontinuing ...

“All-in, while we recognize some aspects to this company’s commercial portfolio has been ... programs, including Repatha and Olpasiran. Maintains the Outperform rating with a price target ...

Repatha (evolocumab) is a prescription drug used in certain situations to lower cholesterol and reduce serious heart-related risks. Repatha does this by attaching itself to a protein in your body ...